Welcome to our dedicated page for Fmc SEC filings (Ticker: FMC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The FMC Corporation (NYSE: FMC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a global agricultural sciences company focused on crop protection, biologicals, crop nutrition, and digital and precision agriculture, FMC uses its SEC reports to detail its financial condition, restructuring activities, capital structure and governance.
Investors can review current reports on Form 8-K, where FMC discloses material events such as quarterly earnings releases, leadership changes, restructuring initiatives and credit agreement amendments. For example, the company has filed 8-Ks describing quarterly financial results, the comprehensive Project Foundation cost optimization plan and Manufacturing Restructuring Program, and an amendment to its Fifth Amended and Restated Credit Agreement that adjusts leverage and interest coverage covenants and places conditions on dividends and indebtedness.
Through its periodic annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via EDGAR and summarized on this page), FMC provides more detailed information on revenue by region, cost structure, research and development spending on new herbicide, insecticide and fungicide active ingredients, and risks related to competition, regulation and restructuring. These filings also describe the company’s geographic footprint, including its headquarters in Philadelphia, Pennsylvania, and its operations across North America, Latin America, Asia and EMEA.
The filings page also highlights governance and board-related disclosures, such as 8-K reports on director resignations or executive departures, and may include proxy materials that discuss executive compensation and board composition. For those monitoring capital structure and liquidity, filings related to credit facilities, covenant changes and potential asset sales—such as the planned divestiture of the India commercial business—are particularly relevant.
Stock Titan enhances these documents with AI-powered summaries that explain key points in plain language, helping users interpret complex sections of lengthy 10-Ks, 10-Qs and 8-Ks. Real-time updates from EDGAR ensure that new filings, including any Form 4 insider transaction reports or additional restructuring disclosures, appear promptly so investors can track how FMC’s financial and strategic decisions evolve over time.
The Vanguard Group filed an amended Schedule 13G/A reporting beneficial ownership of 12,965,507 shares of FMC Corp common stock, representing 10.37% of the class as of the event date of 12/31/2025.
Vanguard reports no sole voting or dispositive power, with shared voting power over 1,042,723 shares and shared dispositive power over 12,965,507 shares. The filing states the FMC shares are held in the ordinary course of business and not for changing or influencing control of FMC.
Vanguard also notes an internal realignment effective 01/12/2026, after which certain subsidiaries or business divisions are expected to report beneficial ownership separately while pursuing the same investment strategies as before the realignment.
A director of FMC Corporation acquired additional common shares through an equity compensation feature rather than an open-market trade. On January 15, 2026, Eduardo E. Cordeiro was issued 88 shares of FMC common stock at a price of $0 per share. These shares were granted pursuant to dividend equivalent rights tied to previously vested restricted stock units held by him.
After this issuance, Cordeiro directly holds 31,634 shares of FMC common stock. The transaction reflects routine alignment of his holdings with dividend payments associated with vested equity awards.
FMC Corporation director Carol Anthony Davidson received 49 shares of FMC common stock on January 15, 2026. The shares were issued at $0 under dividend equivalent rights tied to restricted stock units that had already vested. Following this small equity award, Davidson beneficially owns 23,276 FMC common shares directly.
FMC Corporation director Kathy Lynn Fortmann reported receiving 63 shares of common stock on January 15, 2026. The shares were issued at a price of $0 per share pursuant to dividend equivalent rights tied to vested restricted stock units held by the director. Following this issuance, she beneficially owned 14,326 shares of FMC common stock directly.
FMC Corporation director C. Scott Greer reported a small equity award. On January 15, 2026, he acquired 167 shares of FMC common stock at a price of $0 per share, bringing his directly held beneficial ownership to 74,465 shares. According to the disclosure, these 167 shares were issued under dividend equivalent rights that accrued on previously granted restricted stock units once those units vested. This reflects an automatic, compensation-related share issuance rather than an open-market purchase or sale.
FMC Corporation director K'Lynne Johnson reported a small increase in her direct share ownership through a Form 4 filing. On 01/15/2026, she acquired 146 shares of FMC common stock at a price of $0 per share. The filing explains that these shares were issued as dividend equivalent rights connected to previously vested restricted stock units held by Johnson, meaning she received additional shares in lieu of cash dividends on those units. Following this transaction, she beneficially owns 35,069 FMC common shares directly. This was a routine equity-based compensation-related issuance rather than an open-market purchase or sale.
FMC Corporation director Dirk A. Kempthorne reported receiving 250 shares of FMC common stock on January 15, 2026. The shares were issued at $0 per share as dividend equivalent rights tied to vested restricted stock units held by the reporting person. After this transaction, Kempthorne directly beneficially owns 56,710 shares of FMC common stock.
FMC Corporation director Steven T. Merkt reported a small increase in his ownership of FMC common stock. On 01/15/2026, he acquired 15 shares of common stock at a price of $0 per share, bringing his directly held stake to 5,866 shares.
The filing explains that these shares were issued under dividend equivalent rights tied to vested restricted stock units already held by Merkt. This means he received additional shares to mirror dividends that would have been paid on those underlying restricted stock units, rather than through an open‑market purchase or sale.
FMC Corporation director Margareth Oevrum reported the acquisition of 103 shares of common stock on January 15, 2026. The shares were issued at $0 per share pursuant to dividend equivalent rights connected to vested restricted stock units held by her. Following this issuance, she directly owns 22,409 FMC common shares.
FMC Corporation director Robert C. Pallash received additional equity compensation in the form of common stock. On January 15, 2026, he acquired 306 shares of FMC common stock at a price of $0.00 per share through dividend equivalent rights connected to vested restricted stock units held by him. After this transaction, he directly beneficially owned 60,422 FMC common shares. This was a Form 4 filing by a single reporting person in his capacity as a director, reflecting a routine equity-based compensation accrual rather than an open‑market trade.
FAQ
What is the current stock price of Fmc (FMC)?
What is the market cap of Fmc (FMC)?
